Lexicon Pharmaceuticals
LXRX
137 hedge funds and large institutions have $1.41B invested in Lexicon Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 33
15% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 20
1% more funds holding
Funds holding: 135 → 137 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.4% less ownership
Funds ownership: 109.14% → 108.74% (-0.4%)
25% less capital invested
Capital invested by funds: $1.89B → $1.41B (-$478M)
88% less call options, than puts
Call options by funds: $1.77M | Put options by funds: $14.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$11.3M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$6.06M |
| 3 |
Parallax Volatility Advisers
San Francisco,
California
|
+$5.18M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$4.15M |
| 5 |
PA
Pinnacle Associates
New York
|
+$2.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$12.5M |
| 2 |
KCM
Kingdon Capital Management
New York
|
-$7.96M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.61M |
| 4 |
Millennium Management
New York
|
-$4.56M |
| 5 |
CCI
Columbus Circle Investors
|
-$3.94M |
LXRX Hedge Fund Activity: Q3 2017 in Review
137 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q3 2017, worth a combined $1.41B — down 25% from $1.89B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new LXRX positions and 20 closed out — a net gain of 3 holders — while 44 added to existing stakes and 33 trimmed.
The largest buyer was Kornitzer Capital Management, opening a new position worth an estimated $11.3M. The largest seller was Norges Bank, cutting an estimated $12.5M.
- 137 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q3 2017, up from 135 in Q2 2017.
- Funds reported $1.41B of Lexicon Pharmaceuticals stock for Q3 2017, down 25% quarter-over-quarter.
- 23 funds opened new Lexicon Pharmaceuticals positions in Q3 2017 and 20 closed out, a net change of +3 holders.
- The largest Lexicon Pharmaceuticals buyer in Q3 2017 was Kornitzer Capital Management, an estimated $11.3M added.
- The largest Lexicon Pharmaceuticals seller in Q3 2017 was Norges Bank, an estimated $12.5M sold.
Based on aggregated 13F filings for Q3 2017.